An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain.

Trial Profile

An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Oct 2010

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions
  • Sponsors Javelin Pharmaceuticals
  • Most Recent Events

    • 23 Jun 2009 Status changed from active, no longer recruiting to completed, as reported by Javelin in a media release.
    • 01 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 May 2009 Planned number of patients changed from 700 to 850 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top